ProfileGDS4718 / 219217_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 87% 80% 82% 83% 82% 94% 93% 85% 80% 84% 86% 72% 92% 94% 92% 89% 88% 95% 94% 75% 86% 85% 85% 85% 86% 93% 84% 94% 84% 92% 90% 87% 73% 79% 90% 94% 96% 85% 83% 83% 83% 93% 89% 92% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.8352387
GSM549102patient 115, normal, homogenized [OPG study]7.7858880
GSM549104patient 119, normal, homogenized [OPG study]8.1279582
GSM549108patient 138, normal, homogenized [OPG study]8.0450683
GSM549119patient 077, normal, homogenized [OPG study]7.9947882
GSM549133patient 032, cancer, homogenized [OPG study]10.084194
GSM549139patient 042, cancer, homogenized [OPG study]9.8178393
GSM549099patient 107, normal, homogenized [OPG study]8.3560785
GSM549109patient 139, normal, homogenized [OPG study]7.8473980
GSM549110patient 046, normal, homogenized [OPG study]8.3912884
GSM549114patient 063, normal, homogenized [OPG study]8.6807586
GSM549122patient 082, normal, homogenized [OPG study]7.0239272
GSM549134patient 033, cancer, homogenized [OPG study]9.5871692
GSM549136patient 036, cancer, homogenized [OPG study]10.093294
GSM549140patient 044, cancer, homogenized [OPG study]9.5942992
GSM549111patient 047, normal, homogenized [OPG study]9.1427589
GSM549113patient 057, normal, homogenized [OPG study]9.0690788
GSM549132patient 031, cancer, homogenized [OPG study]10.026395
GSM549137patient 038, cancer, homogenized [OPG study]9.8362794
GSM549142patient 047, cancer, homogenized [OPG study]7.2246575
GSM549100patient 110, normal, homogenized [OPG study]8.4850286
GSM549107patient 135, normal, homogenized [OPG study]8.5482485
GSM549115patient 068, normal, homogenized [OPG study]8.577385
GSM549116patient 072, normal, homogenized [OPG study]8.6030685
GSM549120patient 078, normal, homogenized [OPG study]8.6399286
GSM549131patient 030, cancer, homogenized [OPG study]9.7715793
GSM549118patient 074, normal, homogenized [OPG study]8.3395684
GSM549129patient 027, cancer, homogenized [OPG study]9.7700194
GSM549123patient 088, normal, homogenized [OPG study]8.320784
GSM549124patient 006, cancer, homogenized [OPG study]9.4611592
GSM549126patient 015, cancer, homogenized [OPG study]9.1413190
GSM549128patient 025, cancer, homogenized [OPG study]8.8003787
GSM549103patient 117, normal, homogenized [OPG study]7.0144373
GSM549117patient 073, normal, homogenized [OPG study]7.7078479
GSM549138patient 041, cancer, homogenized [OPG study]9.2764490
GSM549141patient 045, cancer, homogenized [OPG study]9.9761594
GSM549130patient 028, cancer, homogenized [OPG study]10.320796
GSM549101patient 111, normal, homogenized [OPG study]8.4364685
GSM549105patient 128, normal, homogenized [OPG study]8.1097983
GSM549106patient 134, normal, homogenized [OPG study]8.369483
GSM549112patient 048, normal, homogenized [OPG study]8.2154683
GSM549125patient 011, cancer, homogenized [OPG study]9.7403793
GSM549127patient 024, cancer, homogenized [OPG study]8.8945689
GSM549135patient 035, cancer, homogenized [OPG study]9.531892